CMS certification 100034
Mount Sinai Medical Center of Florida, INC
4300 Alton Rd, Miami Beach, FL 33140
Mount Sinai Medical Center of Florida has a CMS overall rating of 3 out of 5 stars. 74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 3. Emergency patients spend a median of 2 h 54 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,966 completed surveys, 24% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | FL | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 335 visits sampled · US median for EDs of the same volume: 3 h 21 min | 2 h 54 min | 2 h 36 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 18 visits sampled | 3 h 33 min | 3 h 40 min | 4 h 17 min |
| Left before being seen Lower is better · 108,631 patients | 1% | 1% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 86 patients | 74% | 73% | 65% |
How Mount Sinai Medical Center of Florida compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Mount Sinai Medical Center of Florida, INCThis hospital | 3/5 | 74% | 2 h 54 min | 3 better 3 worse |
| Larkin Community HospitalSame county · South Miami | 1/5 | 62% | 2 h 7 min | 3 worse |
| South Miami HospitalSame county · Miami | 4/5 | 76% | 3 h 16 min | 5 better 2 worse |
| Jackson Health SystemSame county · Miami | 1/5 | 69% | 3 h 25 min | 3 better 9 worse |
| Coral Gables HospitalSame county · Coral Gables | 3/5 | 66% | 2 h 7 min | 1 better 1 worse |
| Doctors HospitalSame county · Coral Gables | 5/5 | 72% | 2 h 38 min | 3 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 6,072 cases | Too few cases | 3% | 3.9% |
| Heart attack 234 cases | Too few cases | 11.1% | 11.9% |
| Heart failure 444 cases | Too few cases | 9.1% | 11.1% |
| Pneumonia 478 cases | Too few cases | 12.4% | 15.2% |
| Stroke 335 cases | Too few cases | 7.5% | 11.9% |
| COPD 99 cases | Too few cases | 8.5% | 8.6% |
| Heart bypass surgery (CABG) 72 cases | Too few cases | 2.8% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.1 likely 0.83 – 1.36 | 1 |
| After hip or knee replacement 134 cases | Too few cases | 3.2% | 4.1% |
| Deaths after a serious but treatable surgical complication 104 cases | No different | 161.76 per 1,000 likely 116.25 per 1,000 – 207.26 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,924 cases | No different | 0.41 per 1,000 likely 0 per 1,000 – 1 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 8,203 cases | No different | 0.22 per 1,000 likely 0.03 per 1,000 – 0.41 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 8,669 cases | No different | 0.3 per 1,000 likely 0.11 per 1,000 – 0.48 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,164 cases | No different | 3.19 per 1,000 likely 1.85 per 1,000 – 4.53 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 933 cases | No different | 1 per 1,000 likely 0 per 1,000 – 2.35 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 977 cases | Worse | 16.39 per 1,000 likely 11.45 per 1,000 – 21.32 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,295 cases | No different | 4.41 per 1,000 likely 2.53 per 1,000 – 6.29 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 981 cases | No different | 3.9 per 1,000 likely 0.9 per 1,000 – 6.91 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 472 cases | No different | 1.57 per 1,000 likely 0.12 per 1,000 – 3.02 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,843 cases | No different | 1.11 per 1,000 likely 0.21 per 1,000 – 2.01 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 1.26 likely 0.75 – 2 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.46 likely 0.23 – 0.85 | 1 |
| Surgical site infections after colon surgery | Better | 0.16 likely 0.01 – 0.79 | 1 |
| MRSA bloodstream infections | No different | 0.45 likely 0.14 – 1.09 | 1 |
| C. diff intestinal infections | Better | 0.63 likely 0.47 – 0.81 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 519 cases | Too few cases | 13.9% | 14.4% |
| Readmitted after heart failure 1,172 cases | Too few cases | 21.6% | 21.3% |
| Readmitted after pneumonia 965 cases | Too few cases | 17.1% | 17.3% |
| Readmitted after COPD 298 cases | Too few cases | 21.5% | 20% |
| Readmitted after heart bypass surgery 169 cases | Too few cases | 10.8% | 11% |
| Readmitted after hip or knee replacement 139 cases | Too few cases | 5.4% | 5.8% |
| Days back in hospital after a heart attack 246 cases | Too few cases | -2 days per 100 | — |
| Days back in hospital after heart failure 537 cases | Too few cases | -9.2 days per 100 | — |
| Days back in hospital after pneumonia 524 cases | Too few cases | 9.8 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 2,011 cases | No different | 12.7 per 1,000 likely 10.1 per 1,000 – 16 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 261 cases | No different | 9.4 per 100 likely 7.2 per 100 – 12 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 261 cases | No different | 5.5 per 100 likely 4 per 100 – 7.6 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 424 cases | No different | 1.2 likely 0.9 – 1.5 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
488 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 185 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Nurse Anesthetist, Certified Registered | 59 |
| Emergency Medicine | 57 |
| Internal Medicine | 51 |
| Anesthesiology | 31 |
| Family | 26 |
| Physician Assistant | 22 |
| Diagnostic Radiology | 16 |
| Nurse Practitioner | 16 |
| Cardiovascular Disease | 12 |
| Gastroenterology | 12 |
| Acute Care | 11 |
| Specialist | 9 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $1M
- 2020 $643,242
- 2021 $873,357
- 2022 $719,772
- 2023 $1.3M
- 2024 $3.1M
- 2025 $3.8M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $317,100 | 8 |
| Space rental and facility fees | $94,919 | 17 |
| Medical devices and supplies on long-term loan | $88,635 | 11 |
| Education | $10,000 | 2 |
| Faculty and speaker fees for medical education | $6,860 | 1 |
| Speaking, teaching and other services | $5,000 | 1 |
| Consulting fees | $3,000 | 1 |
| Debt forgiveness | $432 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Aadi Bioscience, Inc. | $1.5M | 96 |
| Boehringer Ingelheim International GmbH | $299,500 | 4 |
| Janssen Research & Development, LLC | $272,558 | 45 |
| Pfizer INC. | $199,981 | 35 |
| Merck Sharp & Dohme LLC | $165,636 | 7 |
| Abbvie INC. | $128,059 | 31 |
| Genentech, Inc. | $127,278 | 48 |
| Incyte Corporation | $122,003 | 24 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer Aadi Bioscience, Inc. · NCT05997017 | $1.5M |
| Multicohort Study to Customize Ibrutinib Treatment Regimens for Patients with Previously Untreated Chronic Lymphocytic Leukemia Janssen Research & Development, LLC | $198,305 |
| A Phase 1, Open-Label, Multicenter Study of INCB123667 as Monotherapy in Participants With Selected Advanced Solid Tumors Incyte Corporation | $115,764 |
| A Phase 3 Randomized Open-Label Study of Adjuvant Pembrolizumab With or Without MK-2870 in Participants With Resectable Stage II to IIIB N2 NSCLC not… Merck Sharp & Dohme LLC | $101,232 |
| A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Golcadomide Plus R-CHOP Chemotherapy … Celgene Corporation | $95,423 |
| A Phase 1 Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor BGB-26808 Alone or in … BeiGene, Ltd. · NCT05981703 | $87,424 |
| AN OPENLABEL RANDOMIZED PHASE 3 STUDY OF TUCATINIB IN COMBINATION WITH TRASTUZUMAB AND MFOLFOX6 VERSUS MFOLFOX6 GIVEN WITH OR WITHOUT EITHER CETUXIMA… PFIZER INC. | $70,729 |
| A Phase III, Randomised, Open-label, Global Study of Adjuvant Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig Mo… AstraZeneca Pharmaceuticals LP | $67,404 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Mount Sinai Medical Center of Florida
Is Mount Sinai Medical Center of Florida a good hospital?
Mount Sinai Medical Center of Florida has a CMS overall rating of 3 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 3 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Mount Sinai Medical Center of Florida?
74% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,966 completed HCAHPS surveys.
How long is the wait in the Mount Sinai Medical Center of Florida emergency room?
Emergency patients spend a median of 2 h 54 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Mount Sinai Medical Center of Florida receive money from drug and device companies?
Drug and device makers reported $3.8M in payments to Mount Sinai Medical Center of Florida for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.